EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Testing oral nicotine pouches versus nicotine replacement therapy for cigarette harm reduction in Appalachia: The ARISE study protocol

Amy Wermert, Theodore M Brasky, Alison M Newton, Alice Hinton, Hayley Curran, Amy K Ferketich, Matthew J Carpenter, Peter G Shields, Patrick Tomko iD, Theodore L Wagener, Brittney Keller-Hamilton

PLOS One · 2025

DOI: 10.1371/journal.pone.0338503 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift PLOS One, 2025. Verfasst von Amy Wermert und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Tobacco Research, The Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of Ameri…. Hauptthemen laut MEDLINE: Cigarette Smoking, Harm Reduction, Nicotine, Smoking Cessation. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDA NIH HHS, NCI NIH HHS, National Cancer Institute of the National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

With the highest cancer incidence and mortality rates in the country, rural Appalachia has experienced a decades-long health decline, due in part to high smoking rates. Cigarette smoking prevalence exceeds 30% in much of the region. Oral nicotine pouches (ONPs), which contain nicotine but no tobacco, present an unexplored opportunity to reduce cigarette smoking and cancer incidence.

Objectives

We outline the protocol for the Appalachian Research to Impact Smoking’s Effects (ARISE) study, a randomized controlled trial to determine whether ONPs affect cigarette smoking patterns short- and long-term, and to evaluate their abuse liability versus nicotine replacement therapy (NRT) in a large sample of Appalachian smokers (clinicaltrials.gov: NCT06763536).

Methods

Between 2025 and 2029, we will recruit 1,000 adult smokers living in rural Appalachian counties across 11 states. Participants will be identified via media outreach, mobile cancer screening, community events, and respondent-driven sampling, then randomized to ONP or NRT and complete four study phases: Baseline, Sampling, Switch, and Observation. In the Sampling phase, participants will receive varied flavors and nicotine strengths of their assigned product and select preferred options for use. During the Switch Phase, they will attempt to quit smoking and switch completely to their assigned product. The Observation phase will monitor tobacco use after discontinuation of study products. Study procedures will be conducted online and by mail, including surveys, expired carbon monoxide verification, and product delivery. The primary outcome is 7-day biochemically verified cigarette abstinence at the end of the Switch Phase. Secondary outcomes include switching rates, product appeal, craving, withdrawal, dependence, and purchases during the Observation phase. An intention-to-treat log-binomial regression model will estimate the effect of intervention assignment on cigarette abstinence.

Conclusions

Results will inform whether and how ONPs should be regulated, approached clinically, and used in public health interventions to reduce the burdens of cigarette smoking in Appalachia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cigarette SmokingHarm ReductionNicotineSmoking CessationTobacco Use Cessation DevicesAdultFemaleHumansMaleMiddle AgedAdministration, OralAppalachian RegionNicotine Replacement TherapyRandomized Controlled Trials as Topic

Substanzen

Nicotine

Autor:innen und Institutionen

  • Center for Tobacco Research, The Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America.
  • Division of Medical Oncology, Department of Internal Medicine, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, United States of America.
  • Division of Epidemiology, College of Public Health, The Ohio State University, Columbus, Ohio, United States of America.
  • Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina, United States of America.

ORCID-Profile: Patrick Tomko

Förderung

  • NIDA NIH HHS
  • NCI NIH HHS
  • National Cancer Institute of the National Institutes of Health
  • National Institute on Drug Abuse of the National Institutes of Health

Zitieren

APA

Wermert, A., Brasky, T. M., Newton, A. M., Hinton, A., Curran, H., Ferketich, A. K., Carpenter, M. J., Shields, P. G., Tomko, P., Wagener, T. L., & Keller-Hamilton, B. (2025). Testing oral nicotine pouches versus nicotine replacement therapy for cigarette harm reduction in Appalachia: The ARISE study protocol. PLOS One. https://doi.org/10.1371/journal.pone.0338503

Vancouver

Wermert A, Brasky TM, Newton AM, Hinton A, Curran H, Ferketich AK, et al. Testing oral nicotine pouches versus nicotine replacement therapy for cigarette harm reduction in Appalachia: The ARISE study protocol. PLOS One. 2025. doi:10.1371/journal.pone.0338503

BibTeX
@article{Wermert2025,
  author = {Wermert, Amy and Brasky, Theodore M and Newton, Alison M and Hinton, Alice and Curran, Hayley and Ferketich, Amy K and Carpenter, Matthew J and Shields, Peter G and Tomko, Patrick and Wagener, Theodore L and Keller-Hamilton, Brittney},
  title = {Testing oral nicotine pouches versus nicotine replacement therapy for cigarette harm reduction in Appalachia: The ARISE study protocol},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0338503}
}
Kostenlos starten →